PubMed:11261311 JSONTXT

{"project":"QFMC_MEDLINE","denotations":[{"id":"T1","span":{"begin":106,"end":123},"obj":"DISO"},{"id":"T1c","span":{"begin":106,"end":123},"obj":"UMLS:C0029925"},{"id":"T2","span":{"begin":125,"end":139},"obj":"PROC"},{"id":"T2c","span":{"begin":125,"end":139},"obj":"UMLS:C0021083"},{"id":"T3","span":{"begin":140,"end":150},"obj":"ANAT"},{"id":"T3c","span":{"begin":140,"end":150},"obj":"UMLS:C0682528"}],"relations":[{"id":"#1","pred":"Normalization","subj":"T1","obj":"T1c"},{"id":"#2","pred":"Normalization","subj":"T2","obj":"T2c"},{"id":"#3","pred":"Normalization","subj":"T3","obj":"T3c"}],"namespaces":[{"prefix":"UMLS","uri":"https://uts.nlm.nih.gov/metathesaurus.html#"}],"text":"[Oncogene her-2/neu and ovarian carcinoma: intraperitoneal cellular immunotherapy].\nOncogène her-2/neu et carcinome ovarien: immunothérapie cellulaire intrapéritonéale.\n"}